Abstract
Immunohistochemical staining of p53 was performed using an anti-p53 mouse monoclonal antibody, Pab1801, on 67 colorectal adenocarcinoma specimens to determine the prognostic value of p53 in colorectal cancer patients. Of a total of 67 tumors examined, p53 was detected in 34, but the rate of positive staining for p53 did not correlate with the clinical stage of disease. In 59 patients undergoing curative resection of the tumor, there was no significant difference in the recurrence rate (P = 0.137) or the disease-free survival rate between 28 patients with p53 positive tumors and 31 with p53 negative tumors (P = 0.135).
References
Porter PL, Gown AM, Kramp SG, Coltrera M (1992) Widespread p53 overexpression in human malignant tumors. An immunohistochemical study using methacarn-fixed, embedded tissue. Am J Pathol 140:145–153
Purdie CA, O'Grady J, Piris J, Wyllie AH, Bird CC (1991) p53 expression in colorectal tumors. Am J Pathol 138:807–813
Scott N, Sagar P, Stewart J, Blair GE, Dixon MF, Quirke P (1991) p53 in colorectal cancer: Clinicopathological correlation and prognostic significance. Br J Cancer 63:317–319
Farmer MH (1978) TNM classification of malignant tumors, 3rd edn. International Union Against Cancer, Geneva
Finlay CA, Hinds PW, Levine AJ (1989) The p53 protooncogene can act as a suppressor of transformation. Cell 57:1083–1093
Rogel A, Popliker M, Webb CG, Oren M (1985) p53 cellular tumor antigen: Analysis of mRNA levels in normal adult tissues, embryos, and tumors. Mol Cell Biol 2851–2855
Cattoretti G, Rilke F, Andreola S, D'Amato L, Delia D (1988) p53 expression in breast cancer. Int J Cancer 41:178–183
Iggo R, Gatter K, Bartek J, Lane D, Harris AL (1990) Increased expression of mutant form of p53 oncogene in primary lung cancer. Lancet 335:675–679
Seruca R, David L, Holm R, Nesland JM, Fangan BM, Castedo S, Sobinho-Simoes M, Børresen A-L (1992) p53 mutations in gastric carcinomas. Br J Cancer 65:708–710
Martin HM, Filipe MI, Morris RW, Lane DP, Silvestre F (1992) p53 expression and prognosis in gastric carcinoma. Int J Cancer 50:859–862
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Suzuki, H., Matsumoto, K., Koide, A. et al. Correlation of p53 with the clinicopathologic features and prognosis of colorectal adenocarcinoma. Surg Today 24, 85–87 (1994). https://doi.org/10.1007/BF01676893
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01676893